CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) ROCE % : -1,513.89% (As of Jun. 2018)

View and export this data going back to . Start your Free Trial

What is CTT Pharmaceutical Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. CTT Pharmaceutical Holdings's annualized ROCE % for the quarter that ended in Jun. 2018 was -1,513.89%.

CTT Pharmaceutical Holdings ROCE % Historical Data

The historical data trend for CTT Pharmaceutical Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTT Pharmaceutical Holdings ROCE % Chart

CTT Pharmaceutical Holdings Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

ROCE %

Get a 7-Day Free Trial

-196.12

-3,128.57

-91.80

-158.12

CTT Pharmaceutical Holdings Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Mar17	Jun17	Mar18	Jun18
ROCE %	Get a 7-Day Free Trial															-	-	-	-	-1,513.89

CTT Pharmaceutical Holdings ROCE % Calculation

CTT Pharmaceutical Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2015 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2015 )		(A: Dec. 2014 )		(A: Dec. 2015 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2015 )		(A: Dec. 2014 )		(A: Dec. 2015 )
	=	-1.446	/	( ( (1.662 - 0.169)	+	(0.644 - 0.308) )	/ 2 )
	=	-1.446	/	( (1.493	+	0.336)	/ 2 )
	=	-1.446	/	0.9145
	=	-158.12 %

CTT Pharmaceutical Holdings's ROCE % of for the quarter that ended in Jun. 2018 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2018 )		(Q: Mar. 2018 )		(Q: Jun. 2018 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2018 )		(Q: Mar. 2018 )		(Q: Jun. 2018 )
	=	-4.36	/	( ( (0.156 - 0.283)	+	(0.996 - 0.293) )	/ 2 )
	=	-4.36	/	( ( -0.127	+	0.703 )	/ 2 )
	=	-4.36	/	0.288
	=	-1,513.89 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2018) EBIT data.

CTT Pharmaceutical Holdings (OTCPK:CTTH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

CTT Pharmaceutical Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of CTT Pharmaceutical Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CTT Pharmaceutical Holdings Inc (OTCPK:CTTH) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1100 – 1111 Melville Street, Vancouver, BC, CAN, V6E 3V6

Website

https://www.cttpharmaceuticals.com

CTT Pharmaceutical Holdings Inc is a development stage company specializing in drug delivery systems technology within the pharmaceutical industry. It focuses on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The thin wafers are infused with both natural and synthetic cannabis extracts to deliver treatment as an alternative to smoking and ingestion. Its products include Medwafe, Cannawafe, Vetwafe, and others.

Executives